Non-invasive Prenatal Testing
Enhance maternal and fetal heath using noninvasive prenatal testing
Non-invasive prenatal testing (NIPT) is a highly precise and reliable screening test for detecting the most common chromosomal disorders in a baby before birth. It is an advanced technology that can screen for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome abnormalities with unparalleled accuracy.
NIPT is a non-invasive, safe, and reliable procedure that poses no risk to the mother or the fetus, and it can be performed as early as 11 weeks into the pregnancy.
Non-invasive prenatal testing is offered through our global laboratory network in India. To know more about the test or shipment details, click on request more information button below.
This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.